TAT and Hyperglycemia: In summary, our results reveal that our Tat-fusion constructs with the enzymatic anti-oxidants, MT and/or SOD, either alone but most significantly in combined therapy, inhibited the effects of three different oxidative injuries (hyperglycemia, AGE and 4-HNE exposure), and changes in the pattern of downstream signaling in MCs.